TRX2

TRX2 (PF3D7_1345100) is a component of PTEX, the ATP-powered translocon in the parasitophorous vacuolar membrane (PVM) that exports parasite proteins into the host erythrocyte cytosol (PMID:19536257, PMID:22355694). It adopts a canonical thioredoxin fold with a non-conserved flexible N-terminal extension, is monomeric in solution, and samples both redox catalytic states in the crystal, confirming its identity as a protein disulfide reductase (PMID:25475729). Functionally, TRX2 is non-essential but optimizes translocation: parasites lacking TRX2 show reduced trafficking of all classes of exported proteins beyond the double-membrane barrier, including the virulence factor PfEMP1 (PMID:25043043), and in P. berghei TRX2 deletion causes reduced blood-stage growth, diminished tissue sequestration, and attenuated severe disease in a cerebral malaria model (PMID:23869529, PMID:25820521). TRX2 is a poor substrate for thioredoxin reductase, but its reducing activity can be sustained by the glutathione/glutaredoxin system, linking it to the parasite's broader antioxidant network (PMID:28479253). The precise catalytic function TRX2 performs within the PTEX translocation cycle has not been resolved in the available corpus.

1. 2009 High

   Establishing that TRX2 is a bona fide subunit of an export machine answered where and in what context the protein operates, placing it in the protein-export pathway rather than a free cytosolic redox pool.

   Evidence Biochemical isolation and identification of the PTEX complex from P. falciparum

   PMID:19536257

   Open questions at the time

   • Does not define TRX2's specific molecular contribution to translocation
   • Stoichiometry and assembly order within PTEX unresolved
2. 2011 Medium

   Solving the fold and mapping subcellular location established TRX2 as a thioredoxin-fold protein resident at the PVM, consistent with its PTEX membership.

   Evidence Crystal structure determination and confocal localization of GFP fusions in P. falciparum

   PMID:22355694

   Open questions at the time

   • Functional consequence of the divergent N-terminus unknown
   • Localization based on GFP fusion in a single study
3. 2013 High

   Genetic deletion answered whether TRX2 is required for survival, showing it is dispensable but needed to optimize growth and full virulence.

   Evidence TRX2 knockout in P. berghei with in vivo/in vitro growth and cerebral malaria phenotype assays, independently replicated with endogenous tagging

   PMID:23869529 PMID:24076174

   Open questions at the time

   • Endogenous tag localized to punctate organelles of unknown identity
   • Molecular basis of the growth deficit not defined
4. 2014 High

   Loss-of-function export assays established that TRX2 is required for efficient translocation of all classes of exported proteins, defining its role at the mechanistic level of the export barrier.

   Evidence TRX2 knockout P. falciparum line combined with protein export assays for PEXEL and PEXEL-negative cargo including PfEMP1

   PMID:25043043

   Open questions at the time

   • Whether TRX2 acts as a disulfide reductase on cargo or on the translocon during export is not resolved
   • No direct substrate of TRX2 identified during translocation
5. 2014 High

   High-resolution structural and biophysical analysis confirmed TRX2 is a monomeric protein disulfide reductase, providing the enzymatic identity underlying its export role.

   Evidence X-ray crystallography (2.2 Å), size-exclusion chromatography, and SAXS on recombinant TRX2

   PMID:25475729

   Open questions at the time

   • Physiological substrate of the reductase activity not identified
   • Structure does not reveal how TRX2 engages the PTEX translocon
6. 2015 Medium

   In vivo sequestration assays showed TRX2 contributes to efficient tissue sequestration, connecting its export function to host-interaction phenotypes.

   Evidence TRX2 deletion in P. berghei with tissue sequestration and virulence assays

   PMID:25820521

   Open questions at the time

   • Reduced sequestration not mechanistically linked to a specific exported adhesin in this system
   • Parasites remained virulent, indicating partial redundancy
7. 2017 Medium

   Biochemical reduction assays answered how TRX2 is kept reduced, showing it is a poor thioredoxin-reductase substrate but can be recycled by the glutathione system, revealing cross-talk between antioxidant systems.

   Evidence In vitro reduction assays with recombinant proteins measuring glutathione/thioredoxin system cross-reactivity in P. falciparum

   PMID:28479253

   Open questions at the time

   • Whether glutathione-dependent recycling operates at the PVM in vivo is untested
   • Physiological electron donor during export not established

• The specific disulfide-bond substrate and catalytic step TRX2 performs within the PTEX translocation cycle remain unresolved.
• No cargo or translocon substrate of TRX2's reductase activity identified during export
• Mechanistic link between reductase activity and translocation efficiency unproven